Table 1.

Summary of participants characteristics grouped by high vs low fidelity.

	High fidelity	%	Low fidelity	%
Age
<50	7	47	6	40
≥50	8	53	9	60
Hormone receptor status
Positive	8	53	8	53
Negative	7	47	4	27
Unknown	0	0	3	20
HER2 status
Positive	4	27	5	33
Negative	11	73	9	60
Unknown	0	0	1	7
Cancer stage
II	1	7	7	47
III	14	93	8	53
HIV status
Positive	4	27	6	40
Negative	11	73	9	60
Intent of chemotherapy
Adjuvant	3	20	7	47
Neoadjuvant	12	80	8	53